Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Yamada Y, Osumi T, Kato M, Shioda Y, et al. Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia. J Pediatr Hematol Oncol 2022 Jan 28. pii: 00043426-900000000-96672.
PMID: 35091516


Privacy Policy